Correlation Between GlaxoSmithKline PLC and Madrigal Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Madrigal Pharmaceuticals.

Diversification Opportunities for GlaxoSmithKline PLC and Madrigal Pharmaceuticals

0.52

Correlation Coefficient

GlaxoSmithKline PLC  Madrigal Pharmaceuticals

Very weak diversification

The 3 months correlation between GlaxoSmithKline and Madrigal is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Madrigal Pharmaceuticals go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Madrigal Pharmaceuticals

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.41 times more return on investment than Madrigal Pharmaceuticals. However, GlaxoSmithKline PLC ADR is 2.44 times less risky than Madrigal Pharmaceuticals. It trades about -0.15 of its potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about -0.54 per unit of risk. If you would invest  4,242  in GlaxoSmithKline PLC ADR on January 29, 2024 and sell it today you would lose (131.00) from holding GlaxoSmithKline PLC ADR or give up 3.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

GlaxoSmithKline PLC ADR  vs.  Madrigal Pharmaceuticals

GlaxoSmithKline PLC ADR

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in GlaxoSmithKline PLC ADR are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, GlaxoSmithKline PLC may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Madrigal Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Madrigal Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's technical and fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with GlaxoSmithKline PLC and Madrigal Pharmaceuticals

The main advantage of trading using opposite GlaxoSmithKline PLC and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.

The idea behind GlaxoSmithKline PLC ADR and Madrigal Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.